Rakuten Securities’s Zimmer Biomet ZBH Stock Holding History

Rakuten Securities’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-1	Closed	-$86	–	1019
2026 Q2	$86	Hold	1	–	–	﹤0.01%	872
2026 Q1	$90	Hold	1	–	–	﹤0.01%	838
2025 Q4	$90	Buy	+1	New	+$95	﹤0.01%	852
2024 Q1	–	Sell	-65	Closed	-$7.91K	–	770
2023 Q4	$7.91K	Buy	+65	New	+$7.25K	0.01%	308

Other funds holding ZBH

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Rakuten Securities's ZBH Position: Q3 2026 in Review

Rakuten Securities sold out of Zimmer Biomet (ZBH) in Q3 2026, closing a stake of 1 share — an estimated $86 sold.

Rakuten Securities first reported a position in ZBH in Q4 2023 and held it in 4 quarters. The position peaked at $7.91K in Q4 2023. 651 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

Rakuten Securities reported no remaining Zimmer Biomet position as of Q3 2026 after selling out during the quarter.
Rakuten Securities sold 1 Zimmer Biomet share in Q3 2026, an estimated $86.
Rakuten Securities first reported a position in Zimmer Biomet in Q4 2023 and held it in 4 quarters.
Rakuten Securities's Zimmer Biomet position peaked at $7.91K in Q4 2023.
651 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Rakuten Securities's 13F filing for Q3 2026, filed 2 Nov 2026.